Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 HKD | -1.41% | -1.41% | -12.50% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 115.6 | 112.7 | 70.77 | 78.42 | 51.45 | 36.83 |
Enterprise Value (EV) 1 | 63.17 | 75.07 | 19.26 | 23 | 17.62 | 30.85 |
P/E ratio | 13.8 x | 24.4 x | 14.1 x | 118 x | -3.18 x | -0.86 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 0.53 x | 0.39 x | 0.3 x | 0.36 x | 0.38 x | 0.38 x |
EV / Revenue | 0.29 x | 0.26 x | 0.08 x | 0.11 x | 0.13 x | 0.31 x |
EV / EBITDA | 9.64 x | 16.1 x | 3 x | -1.95 x | -0.95 x | -0.78 x |
EV / FCF | 10.4 x | -10.3 x | 1.21 x | 6.23 x | -0.62 x | -1.65 x |
FCF Yield | 9.59% | -9.67% | 82.5% | 16.1% | -162% | -60.8% |
Price to Book | 1.12 x | 1.05 x | 0.63 x | 0.69 x | 0.53 x | 0.68 x |
Nbr of stocks (in thousands) | 506,546 | 506,546 | 506,546 | 506,546 | 506,546 | 506,546 |
Reference price 2 | 0.2283 | 0.2225 | 0.1397 | 0.1548 | 0.1016 | 0.0727 |
Announcement Date | 3/28/19 | 3/30/20 | 3/30/21 | 3/30/22 | 3/30/23 | 4/18/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 217.1 | 291.5 | 237.6 | 218.4 | 135 | 98.09 |
EBITDA 1 | 6.554 | 4.658 | 6.418 | -11.81 | -18.51 | -39.66 |
EBIT 1 | 5.884 | 4.131 | 5.986 | -12.84 | -20.23 | -40.6 |
Operating Margin | 2.71% | 1.42% | 2.52% | -5.88% | -14.98% | -41.39% |
Earnings before Tax (EBT) 1 | 8.223 | 3.873 | 5.678 | -12.65 | -19.18 | -42.09 |
Net income 1 | 8.393 | 4.614 | 5.025 | 0.665 | -16.17 | -42.77 |
Net margin | 3.87% | 1.58% | 2.11% | 0.3% | -11.97% | -43.61% |
EPS 2 | 0.0166 | 0.009108 | 0.009920 | 0.001312 | -0.0319 | -0.0844 |
Free Cash Flow 1 | 6.056 | -7.261 | 15.89 | 3.691 | -28.56 | -18.74 |
FCF margin | 2.79% | -2.49% | 6.69% | 1.69% | -21.15% | -19.11% |
FCF Conversion (EBITDA) | 92.4% | - | 247.6% | - | - | - |
FCF Conversion (Net income) | 72.16% | - | 316.23% | 555.04% | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/28/19 | 3/30/20 | 3/30/21 | 3/30/22 | 3/30/23 | 4/18/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | - |
Net Cash position 1 | 52.5 | 37.7 | 51.5 | 55.4 | 33.8 | 5.99 |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 6.06 | -7.26 | 15.9 | 3.69 | -28.6 | -18.7 |
ROE (net income / shareholders' equity) | 7.85% | 3.51% | 5.35% | -12.5% | -18.8% | -56.6% |
ROA (Net income/ Total Assets) | 3.03% | 1.7% | 2.45% | -5.05% | -8.43% | -24% |
Assets 1 | 276.7 | 270.8 | 205.4 | -13.18 | 191.7 | 178.2 |
Book Value Per Share 2 | 0.2000 | 0.2100 | 0.2200 | 0.2200 | 0.1900 | 0.1100 |
Cash Flow per Share 2 | 0.0700 | 0.0600 | 0.0600 | 0.0800 | 0.0500 | 0.0300 |
Capex 1 | 0.48 | 0.2 | 0.48 | 5.78 | 2.94 | 0.85 |
Capex / Sales | 0.22% | 0.07% | 0.2% | 2.65% | 2.18% | 0.87% |
Announcement Date | 3/28/19 | 3/30/20 | 3/30/21 | 3/30/22 | 3/30/23 | 4/18/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-12.50% | 4.53M | |
+63.48% | 89.27B | |
-6.95% | 27.4B | |
+1.12% | 22.32B | |
+0.78% | 18.07B | |
-17.31% | 14.31B | |
-8.90% | 12.3B | |
+9.13% | 10.03B | |
+14.60% | 9.94B | |
-14.40% | 9.54B |
- Stock Market
- Equities
- 8106 Stock
- Financials Shenghua Lande Scitech Limited